Björn Meyer

Sep 16, 2024 | fis.uke.de | Björn Meyer |Outpatients Clinic |Linda T. Betz |Gitta A Jacob

BACKGROUND: Multiple Sclerosis (MS) is a chronic inflammatory neurodegenerative disease with diverse symptomatology, significantly impacting patients' quality of life (QoL). While pharmacological therapies focus primarily on reducing inflammation and relapse rates, non-pharmacological interventions, including digital health applications, have shown promise in improving QoL among persons with MS (PwMS).